201 related articles for article (PubMed ID: 7247360)
1. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
[TBL] [Abstract][Full Text] [Related]
2. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
Pancoast SJ; Hyams DM; Neu HC
Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
[TBL] [Abstract][Full Text] [Related]
3. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
4. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
5. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
Harding GK; Ronald AR; Boutros P; Lank B
Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.
Wright SW; Wrenn KD; Haynes ML
J Gen Intern Med; 1999 Oct; 14(10):606-9. PubMed ID: 10571705
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
Wong CK; Harding GK; Ronald AR; Hoban S
Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
[TBL] [Abstract][Full Text] [Related]
8. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
Smellie JM; Grüneberg RN; Normand IC; Bantock HM
Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
Stein GE; Gurwith D; Gurwith M
Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
[TBL] [Abstract][Full Text] [Related]
11. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.
DuPont HL; Reves RR; Galindo E; Sullivan PS; Wood LV; Mendiola JG
N Engl J Med; 1982 Sep; 307(14):841-4. PubMed ID: 7050714
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
[TBL] [Abstract][Full Text] [Related]
14. Emergence of trimethoprim resistance in fecal flora.
Huovinen P; Mattila T; Kiminki O; Pulkkinen L; Huovinen S; Koskela M; Sunila R; Toivanen P
Antimicrob Agents Chemother; 1985 Aug; 28(2):354-6. PubMed ID: 3834839
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
Gribble MJ; Puterman ML
Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
[TBL] [Abstract][Full Text] [Related]
16. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
19. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
[TBL] [Abstract][Full Text] [Related]
20. Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.
Goldstein BP; Ripamonti IF; Bolzoni G; Carniti G; Arioli V
Antimicrob Agents Chemother; 1979 Dec; 16(6):736-42. PubMed ID: 533255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
